MedPath

The effect of clove in depressio

Phase 3
Registration Number
IRCT20211223053499N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Aged 18 to 65 years
A patient with major depressive disorder or bipolar disorder in the depressive episode

Exclusion Criteria

Existence of psychotic symptoms
Cognition disorders
Anxiety disorders
Schizophrenia
Antisocial personality disorder
Mental retardation
Dementia
Pregnancy
Lactation
Explicit suicidal ideation
History of allergy to herbal drugs
Having a proven problem with the sense of smell

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression rate. Timepoint: Weeks 0, 4 and 8 after the start of the intervention. Method of measurement: Hamilton Depression Inventory 17 items and Clinical Global Impression Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath